NasdaqGM - Delayed Quote USD
Harvard Bioscience, Inc. (HBIO)
0.5088
-0.0146
(-2.79%)
At close: June 13 at 4:00:02 PM EDT
0.5031
-0.01
(-1.12%)
After hours: June 13 at 7:57:40 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
3,023
1,440
14,028
1,152
1,262
Investing Cash Flow
-1,802
-1,344
-1,799
-1,590
-1,345
Financing Cash Flow
-280
-131
-12,134
-2,837
-252
End Cash Position
5,196
4,108
4,283
4,508
7,821
Income Tax Paid Supplemental Data
--
--
207
534
577
Interest Paid Supplemental Data
3,266
3,235
3,795
2,314
1,577
Capital Expenditure
-3,226
-3,263
-2,311
-1,590
-1,345
Issuance of Debt
6,300
8,800
4,500
7,800
4,250
Repayment of Debt
-6,050
-8,573
-15,041
-9,586
-4,200
Free Cash Flow
-203
-1,823
11,717
-438
-83
12/31/2021 - 3/19/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GCTK GlucoTrack, Inc.
0.0949
-10.39%
STSS Sharps Technology, Inc.
5.45
-7.47%
MBOT Microbot Medical Inc.
2.3400
-5.65%
LUCY Innovative Eyewear, Inc.
2.4500
-8.41%
POAI Predictive Oncology Inc.
0.9600
-3.03%
AKYA Akoya Biosciences, Inc.
1.2300
-2.38%
EKSO Ekso Bionics Holdings, Inc.
3.8400
-0.26%
MHUA Meihua International Medical Technologies Co., Ltd.
0.3407
-10.34%
NVST Envista Holdings Corporation
18.45
-2.23%
COO The Cooper Companies, Inc.
69.70
-1.66%